EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core. The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user. Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (5 days ago)
We have extended the early bird deadline for #eCheminfo Workshop in Drug Design to May 31: https://t.co/NxBAmGIFtz
Douglas Connect (4 weeks ago)
Deadline of the early-bird rate and the bursary applications for the #eChemInfo workshop is less then one week away. https://t.co/NxBAmGIFtz
Douglas Connect (6 weeks ago)
RT @barryhardy: #OpenTox Asia 2017 detailed program available #toxicology #safety #risk #3Rs #insilico #invitro #Korea @DouglasConn https:/…
Douglas Connect (2 months ago)
Your input is needed to the #OpenRiskNet eInfrastructure design supporting #datasharing #modelling #RiskAssessment https://t.co/ANfwQRpqVj
Douglas Connect (2 months ago)
"2nd Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano" https://t.co/iYP1zNEWTX on @LinkedIn

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com